[go: up one dir, main page]

EP4271213A4 - COMPOSITIONS AND METHODS OF SUBLINGUAL ADMINISTRATION OF NICOTINE - Google Patents

COMPOSITIONS AND METHODS OF SUBLINGUAL ADMINISTRATION OF NICOTINE Download PDF

Info

Publication number
EP4271213A4
EP4271213A4 EP23723800.1A EP23723800A EP4271213A4 EP 4271213 A4 EP4271213 A4 EP 4271213A4 EP 23723800 A EP23723800 A EP 23723800A EP 4271213 A4 EP4271213 A4 EP 4271213A4
Authority
EP
European Patent Office
Prior art keywords
nicotine
compositions
methods
sublingual administration
sublingual
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
EP23723800.1A
Other languages
German (de)
French (fr)
Other versions
EP4271213A1 (en
Inventor
John Docherty
Andrew BUNKA
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Poviva Corp
Original Assignee
Poviva Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US17/700,646 external-priority patent/US20230301341A1/en
Priority claimed from US17/700,628 external-priority patent/US11700875B1/en
Application filed by Poviva Corp filed Critical Poviva Corp
Priority claimed from PCT/US2023/015626 external-priority patent/WO2023183227A1/en
Publication of EP4271213A1 publication Critical patent/EP4271213A1/en
Publication of EP4271213A4 publication Critical patent/EP4271213A4/en
Withdrawn legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/10Chemical features of tobacco products or tobacco substitutes
    • A24B15/16Chemical features of tobacco products or tobacco substitutes of tobacco substitutes
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B13/00Tobacco for pipes, for cigars, e.g. cigar inserts, or for cigarettes; Chewing tobacco; Snuff
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/28Treatment of tobacco products or tobacco substitutes by chemical substances
    • AHUMAN NECESSITIES
    • A24TOBACCO; CIGARS; CIGARETTES; SIMULATED SMOKING DEVICES; SMOKERS' REQUISITES
    • A24BMANUFACTURE OR PREPARATION OF TOBACCO FOR SMOKING OR CHEWING; TOBACCO; SNUFF
    • A24B15/00Chemical features or treatment of tobacco; Tobacco substitutes, e.g. in liquid form
    • A24B15/18Treatment of tobacco products or tobacco substitutes
    • A24B15/28Treatment of tobacco products or tobacco substitutes by chemical substances
    • A24B15/30Treatment of tobacco products or tobacco substitutes by chemical substances by organic substances
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465Nicotine; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0053Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/006Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/143Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with inorganic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Toxicology (AREA)
  • Inorganic Chemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
EP23723800.1A 2022-03-22 2023-03-20 COMPOSITIONS AND METHODS OF SUBLINGUAL ADMINISTRATION OF NICOTINE Withdrawn EP4271213A4 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US17/700,646 US20230301341A1 (en) 2022-03-22 2022-03-22 Compositions and methods for sublingual delivery of nicotine
US17/700,628 US11700875B1 (en) 2022-03-22 2022-03-22 Compositions and methods for sublingual delivery of nicotine
PCT/US2023/015626 WO2023183227A1 (en) 2022-03-22 2023-03-20 Compositions and methods for sublingual delivery of nicotine

Publications (2)

Publication Number Publication Date
EP4271213A1 EP4271213A1 (en) 2023-11-08
EP4271213A4 true EP4271213A4 (en) 2024-08-28

Family

ID=88069090

Family Applications (1)

Application Number Title Priority Date Filing Date
EP23723800.1A Withdrawn EP4271213A4 (en) 2022-03-22 2023-03-20 COMPOSITIONS AND METHODS OF SUBLINGUAL ADMINISTRATION OF NICOTINE

Country Status (5)

Country Link
EP (1) EP4271213A4 (en)
JP (2) JP2024514732A (en)
AU (1) AU2023238723A1 (en)
CA (1) CA3196913A1 (en)
MX (1) MX2023009659A (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE540813C2 (en) * 2017-04-24 2018-11-20 Swedish Match North Europe Ab A flavoured moist oral pouched nicotine product comprising
WO2018233795A1 (en) * 2017-06-23 2018-12-27 Fertin Pharma A/S NICOTINE POCKET
WO2020244721A1 (en) * 2019-06-07 2020-12-10 Ncp Nextgen A/S Nicotine pouch composition and pouch comprising such
US20210345656A1 (en) * 2017-12-08 2021-11-11 Fertin Pharma A/S High nicotine absorption

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018197454A1 (en) * 2017-04-24 2018-11-01 Swedish Match North Europe Ab A flavoured moist oral pouched nicotine product comprising triglyceride
AU2019256805B2 (en) * 2018-04-16 2022-03-03 Poviva Corp. Compositions infused with nicotine compounds and methods of use thereof
BR112022024943A2 (en) * 2020-06-08 2022-12-27 Nicoventures Trading Ltd EFERVESCENT ORAL COMPOSITION COMPRISING AN ACTIVE INGREDIENT

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE540813C2 (en) * 2017-04-24 2018-11-20 Swedish Match North Europe Ab A flavoured moist oral pouched nicotine product comprising
WO2018233795A1 (en) * 2017-06-23 2018-12-27 Fertin Pharma A/S NICOTINE POCKET
US20210345656A1 (en) * 2017-12-08 2021-11-11 Fertin Pharma A/S High nicotine absorption
WO2020244721A1 (en) * 2019-06-07 2020-12-10 Ncp Nextgen A/S Nicotine pouch composition and pouch comprising such

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
See also references of WO2023183227A1 *

Also Published As

Publication number Publication date
JP2025178423A (en) 2025-12-05
AU2023238723A1 (en) 2024-08-15
EP4271213A1 (en) 2023-11-08
MX2023009659A (en) 2023-10-13
JP2024514732A (en) 2024-04-03
CA3196913A1 (en) 2023-09-22

Similar Documents

Publication Publication Date Title
EP4090674A4 (en) METHODS AND COMPOSITIONS OF BIASED IL2 MUTEINS
EP4346788A4 (en) ENANTIOMERIC ENTACTOGENIC COMPOSITIONS AND METHODS OF USE THEREOF
MA71697A (en) COMPOSITIONS AND METHODS FOR INHIBITING KRAS
EP4308556A4 (en) AMINOHETEROARYL COMPOUNDS AND COMPOSITIONS
EP4121022A4 (en) COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CORONAVIRUS INFECTION
EP4313002A4 (en) POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS AND METHODS OF USE THEREOF
EP4284417A4 (en) COMPOSITIONS AND METHODS OF TREATMENT OF HEREDITARY ANGIEDEMA
EP4271213A4 (en) COMPOSITIONS AND METHODS OF SUBLINGUAL ADMINISTRATION OF NICOTINE
IL315052A (en) Compositions of hydroxypropyl-beta-cyclodextrin and purification methods
EP4308703A4 (en) POLYNUCLEOTIDE COMPOSITIONS, RELATED FORMULATIONS AND METHODS OF USE THEREOF
EP4463469A4 (en) DESIGNED CYTOKIN COMPOSITIONS AND METHODS OF ADMINISTRATION
EP4117654C0 (en) Compositions for the treatment of infections and for the interruption of biofilm formation
EP4157328A4 (en) COMPOSITIONS AND METHODS FOR INHIBITING PROLIFERATION OF VASCULAR SMOOTH MUSCLE CELLS
EP4100430A4 (en) COMPOSITIONS AND METHODS FOR TREATMENT OF PULMONARY HYPERTENSION
EP4297726A4 (en) INJECTABLE FORMULATION OF SODIUM BICARBONATE AND METHODS OF USE THEREOF
EP4181689A4 (en) COMPOSITION OF TASTE ENHANCER
EP4251199A4 (en) METHODS AND COMPOSITIONS FOR THE TREATMENT OF VIRAL INFECTION
EP4203939A4 (en) COMPOSITIONS AND METHODS OF ADMINISTRATION OF LEVODOPA
EP4132470A4 (en) COMPOSITIONS AND METHODS FOR TREATMENT AND PREVENTION OF LUNG DISEASE
EP4203946A4 (en) CANNABINOID FORMULATIONS AND METHODS OF USE
EP4251168A4 (en) COMPOSITIONS COMPRISING FLUMAZENIL AND NALTREXONE AND METHODS OF USE THEREOF
EP4232569A4 (en) COMPOSITIONS AND METHODS OF RNA SYNTHESIS
EP4346802A4 (en) COMPOSITIONS AND METHODS OF TREATMENT OF HYPERTENSION
EP4153617A4 (en) PREPARATION AND PURIFICATION OF HYPERSIALYLATED IGG
EP4284443A4 (en) METHODS OF SYNTHESIS AND COMPOSITIONS OF WEAK INTERMEDIATE CONTRAST AGENTS AND WEAK DICHELATE INTERMEDIATE CONTRAST AGENTS

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: UNKNOWN

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20230523

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC ME MK MT NL NO PL PT RO RS SE SI SK SM TR

RIN1 Information on inventor provided before grant (corrected)

Inventor name: BUNKA, ANDREW

Inventor name: DOCHERTY, JOHN

A4 Supplementary search report drawn up and despatched

Effective date: 20240731

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 9/14 20060101ALI20240725BHEP

Ipc: A24B 13/00 20060101ALI20240725BHEP

Ipc: A24B 15/28 20060101ALI20240725BHEP

Ipc: A61K 31/465 20060101ALI20240725BHEP

Ipc: A61K 9/00 20060101ALI20240725BHEP

Ipc: A24B 15/16 20200101ALI20240725BHEP

Ipc: A24B 15/30 20060101ALI20240725BHEP

Ipc: A24B 15/10 20060101ALI20240725BHEP

Ipc: A24B 15/18 20060101AFI20240725BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20250409

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN

18D Application deemed to be withdrawn

Effective date: 20250812